Abstract
Background: There is a link between diabetic peripheral neuropathy (DPN) progression and the increase in the cross-sectional area (CSA) of the tibial nerve at the ankle. Nevertheless, no prior meta-analysis has been conducted to evaluate its usefulness for the diagnosis of DPN. Methods: We searched Google Scholar, Scopus, and PubMed for potential studies. Studies had to report tibial nerve CSA at the ankle and diabetes status (DM, DPN, or healthy) to be included. A random-effect meta-analysis was applied to calculate pooled tibial nerve CSA and mean differences across the groups. Subgroup and correlational analyses were conducted to study the potential covariates. Results: The analysis of 3295 subjects revealed that tibial nerve CSA was 13.39 mm2 (CI: 10.94–15.85) in DM patients and 15.12 mm2 (CI: 11.76–18.48) in DPN patients. The CSA was 1.93 mm2 (CI: 0.92–2.95, I2 = 98.69%, p < 0.01) larger than DPN-free diabetic patients. The diagnostic criteria of DPN and age were also identified as potential moderators of tibial nerve CSA. Conclusions: Although tibial nerve CSA at the ankle was significantly larger in the DPN patients, its clinical usefulness is limited by the overlap between groups and the inconsistency in the criteria used to diagnose DPN.
Reference38 articles.
1. Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in primary health care setting;Int. J. Health Sci.,2012
2. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas;Diabetes Res. Clin. Pract.,2019
3. The diabetic foot: The scope of the problem;J. Fam. Pract.,2000
4. Neuropathy: Mobility and quality of life;Diabetes Metab. Res. Rev.,2008
5. The health care costs of diabetic peripheral neuropathy in the US;Diabetes Care,2003
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献